SCHEMBL470256

SCHEMBL470256

Cc1nc2cc(-c3ccccc3)nn2c(-c2ccc(O)c(C(F)(F)F)c2)c1C(OC(C)(C)C)C(=O)O

nearest known ligand 0.58

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
NR1I2 O75469 1/20 0.58
MAPT P10636 4/20 0.38
ALDH1A1 P00352 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
KDM4E B2RXH2 2/20 0.37
NPC1 O15118 3/20 0.37
RAB9A P51151 3/20 0.37
TP53 P04637 2/20 0.37
HPGD P15428 1/20 0.37
NFKB1 P19838 1/20 0.37
HTT P42858 1/20 0.37
NFKB2 Q00653 1/20 0.37
RELA Q04206 1/20 0.37
PSIP1 O75475 1/20 0.37
TDP1 Q9NUW8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL470257 0.90 NR1I2 (0.63) NR1I2MAPTALDH1A1SMN1; SMN2KDM4E
SCHEMBL10174794 0.90 NR1I2 (0.60) NR1I2MAPTALDH1A1SMN1; SMN2KDM4E
SCHEMBL12090993 0.90 NR1I2 (0.57) NR1I2MAPTALDH1A1SMN1; SMN2KDM4E
SCHEMBL10174788 0.88 NR1I2 (0.61) NR1I2MAPTALDH1A1SMN1; SMN2KDM4E
SCHEMBL12091025 0.87 NR1I2 (0.66) NR1I2MAPTALDH1A1SMN1; SMN2KDM4E
SCHEMBL10175625 0.87 NR1I2 (0.57) NR1I2MAPTALDH1A1SMN1; SMN2NPC1
SCHEMBL470358 0.87 NR1I2 (0.64) NR1I2MAPTALDH1A1SMN1; SMN2KDM4E
SCHEMBL470254 0.86 NR1I2 (0.62) NR1I2MAPTALDH1A1SMN1; SMN2KDM4E
SCHEMBL12091038 0.86 NR1I2 (0.66) NR1I2MAPTALDH1A1SMN1; SMN2KDM4E
SCHEMBL470281 0.86 NR1I2 (0.66) NR1I2MAPTALDH1A1SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012033735-A1 INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-15 WO disclosed